RECRUITING

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery

Official Title

A Prospective, Single-Arm Study Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of Dry Eye Disease in Patients Undergoing Refractive Cataract Surgery

Quick Facts

Study Start:2025-09-03

Study Completion:2026-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT07155057

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:22 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Be willing and able to understand and sign the informed consent form (ICF) * Men or non-pregnant women age 22 or older * Clear intraocular media other than cataract * Diagnosis of dry eye disease (OSDI score ≥ 13) * Non-invasive Tear break up time ≤ 10 seconds in at least one eye * Willing and able to comply with all study related visits and procedures * In the opinion of the investigator, patients who are appropriate for advanced technology lens implants	* History of punctal cautery * Lacrimal anatomy (e.g., nasolacrimal duct obstruction) that per investigator suggests that the patient would not be a good candidate for lacrimal occlusion or patients for whom lacrimal occlusion would increase risk

Inclusion Criteria

Exclusion Criteria

* Be willing and able to understand and sign the informed consent form (ICF)
* Men or non-pregnant women age 22 or older
* Clear intraocular media other than cataract
* Diagnosis of dry eye disease (OSDI score ≥ 13)
* Non-invasive Tear break up time ≤ 10 seconds in at least one eye
* Willing and able to comply with all study related visits and procedures
* In the opinion of the investigator, patients who are appropriate for advanced technology lens implants

* History of punctal cautery
* Lacrimal anatomy (e.g., nasolacrimal duct obstruction) that per investigator suggests that the patient would not be a good candidate for lacrimal occlusion or patients for whom lacrimal occlusion would increase risk

Contacts and Locations

Study Contact

Tiffany Facile

CONTACT

605-371-7075

tiffany.facile@vancethompsonvision.com

Principal Investigator

Kayla Karpuk, OD

PRINCIPAL_INVESTIGATOR

Vance Thompson Vision Clinic Prof. LLC

Vance Thompson, MD

PRINCIPAL_INVESTIGATOR

Vance Thompson Vision Clinic Prof. LLC

Study Locations (Sites)

Vance Thompson Vision Clinic, Prof. LLC

Sioux Falls, South Dakota, 57105

United States

Collaborators and Investigators

Sponsor: Vance Thompson Vision

Kayla Karpuk, OD, PRINCIPAL_INVESTIGATOR, Vance Thompson Vision Clinic Prof. LLC
Vance Thompson, MD, PRINCIPAL_INVESTIGATOR, Vance Thompson Vision Clinic Prof. LLC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09-03

Study Completion Date2026-12

Study Record Updates

Study Start Date2025-09-03

Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

Dry Eye Disease (DED)